A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)
Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The main purpose of the study is to evaluate the efficacy and safety of the study drug known
as prasugrel for the reduction of Vaso-Occlusive Crisis events in pediatric participants with
sickle cell disease. The study will also investigate reduction in daily pain in children who
have sickle cell disease.